Moderna, Inc.
Ticker
MRNA
ISIN
US60770K1079
Price
-
Change Today
-
Price 1 year ago
-
Market Capitalization
58,984,861,696.00
Price evolution
Yearly Returns
Peers
Peers
Company information
Summary
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
NMS
Earnings Per Share
-1.959
P/E Ratio
4.505931
Debt/Equity Ratio
5.546
Beta
1.646803
Ebitda
16,552,999,936.00
Ebitda Margins
0.73
Enterprise to Ebitda
3.39
Enterprise Value
56,100,360,192.00
Target Price
-
Estimated Price
-
Book Value
6.42
Expected Growth
-
Balance sheet
Income statement
Sustainability
Correlation
| Company | Name | Correlation |
|---|---|---|
| 600866.SS | STAR LAKE BIOSCIENCE CO INC Z | -0.244 |
| 300181.SZ | ZHEJIANG JOLLY PHA | -0.153 |
| ALPHA.PA | PHARNEXT | -0.084 |
| 1873.HK | VIVA BIOTECH | -0.073 |
| 2137.HK | BRII-B | -0.058 |
| 1801.HK | INNOVENT BIO | -0.011 |
| 002007.SZ | HUALAN BIOLOGICAL | -0.007 |
| 300009.SZ | ANHUI ANKE BIOTECH | 0.002 |
| BLUE | bluebird bio, Inc. | 0.013 |
| 2370.T | MEDINET CO LTD | 0.028 |
| 600200.SS | JIANGSU WUZHONG PHARMACEUTICAL | 0.044 |
| 300147.SZ | XIANGXUE PHARMACEU | 0.054 |
| 300122.SZ | CHONGQING ZHIFEI B | 0.081 |
| 002252.SZ | S/H RAAS BLOOD PRO | 0.127 |
| 2269.HK | WUXI BIO | 0.140 |
| 300204.SZ | STAIDSON (BEIJING) | 0.142 |
| AKBA | Akebia Therapeutics, Inc. | 0.143 |
| 600201.SS | JINYU BIO-TECHNOLOGY CO LTD | 0.144 |
| 300363.SZ | PORTON PHARMA SOLU | 0.150 |
| TMBR | Timber Pharmaceuticals, Inc. | 0.176 |
| 1177.HK | SINO BIOPHARM | 0.198 |
| ATHX | Athersys, Inc. | 0.200 |
| IMU.AX | IMUGENE FPO | 0.221 |
| 300497.SZ | JIANGXI FUSHINE PH | 0.221 |
| DNA | Ginkgo Bioworks Holdings, Inc. | 0.230 |
| 1530.HK | 3SBIO | 0.321 |
| 0775.HK | CKLIFE SCIENCES | 0.325 |
| TRX.L | TISSUE REGENIX GROUP PLC | 0.628 |
Similar companies
| Ticker | Name | City | Country | Currency | Exchange | Beta | EV/EBITDA | Employees | Site |
|---|---|---|---|---|---|---|---|---|---|
| ALPHA.PA | PHARNEXT | Issy-les-Moulineaux | France | EUR | PAR | 2.864 | -0.651 | 40 | https://www.pharnext.com |
| 1177.HK | SINO BIOPHARM | Wan Chai | Hong Kong | HKD | HKG | 0.478 | 17.584 | 25579 | https://www.sinobiopharm.com |
| 0775.HK | CKLIFE SCIENCES | Tai Po | Hong Kong | HKD | HKG | 0.404 | 32.464 | 1855 | https://www.ck-lifesciences.com |
| DNA | Ginkgo Bioworks Holdings, Inc. | Boston | United States | USD | NYQ | -1.244 | 641 | https://www.ginkgobioworks.com | |
| 002252.SZ | S/H RAAS BLOOD PRO | Shanghai | China | CNY | SHZ | 0.211 | 19.620 | 2966 | https://www.raas-corp.com |
| 002007.SZ | HUALAN BIOLOGICAL | Xinxiang | China | CNY | SHZ | 0.028 | 19.245 | 2927 | https://www.hualanbio.com |
| 600200.SS | JIANGSU WUZHONG PHARMACEUTICAL | Suzhou | China | CNY | SHH | 0.563 | -710.433 | https://www.600200.com | |
| 600866.SS | STAR LAKE BIOSCIENCE CO INC Z | Zhaoqing | China | CNY | SHH | 0.350 | 21.346 | 2608 | https://www.starlake.com.cn |
| TRX.L | TISSUE REGENIX GROUP PLC | Garforth | United Kingdom | GBp | LSE | 1.398 | -10.940 | 79 | https://www.tissueregenix.com |
| 2269.HK | WUXI BIO | Wuxi | China | HKD | HKG | 0.908 | 85.173 | 9864 | https://www.wuxibiologics.com |
| IMU.AX | IMUGENE FPO | Sydney | Australia | AUD | ASX | 2.281 | -30.301 | https://www.imugene.com | |
| 600201.SS | JINYU BIO-TECHNOLOGY CO LTD | Hohhot | China | CNY | SHH | 0.307 | 18.759 | 1580 | https://www.jinyu.com.cn |
| TMBR | Timber Pharmaceuticals, Inc. | Basking Ridge | United States | USD | ASE | 0.191 | 5 | https://www.timberpharma.com | |
| 300181.SZ | ZHEJIANG JOLLY PHA | Huzhou | China | CNY | SHZ | 0.095 | 18.504 | 2132 | https://www.zuoli.com |
| CLVS | Clovis Oncology, Inc. | Boulder | United States | USD | NMS | 0.489 | -3.779 | 413 | https://www.clovisoncology.com |
| ATHX | Athersys, Inc. | Cleveland | United States | USD | NCM | -1.304 | -0.603 | 104 | https://www.athersys.com |
| VTGN | VistaGen Therapeutics, Inc. | South San Francisco | United States | USD | NCM | 1.065 | 0.746 | 36 | https://www.vistagen.com |
| 300009.SZ | ANHUI ANKE BIOTECH | Hefei | China | CNY | SHZ | 0.384 | 19.323 | https://www.ankebio.com | |
| 300122.SZ | CHONGQING ZHIFEI B | Chongqing | China | CNY | SHZ | 0.765 | 11.890 | 4800 | https://www.zhifeishengwu.com |
| 2370.T | MEDINET CO LTD | Tokyo | Japan | JPY | JPX | 1.344 | -2.690 | 92 | https://www.medinet-inc.co.jp |
| 2137.HK | BRII-B | Beijing | China | HKD | HKG | -5.411 | 113 | https://www.briibio.com | |
| 1530.HK | 3SBIO | Shenyang | China | HKD | HKG | 0.838 | 6.754 | 5292 | https://www.3sbio.com |
| 1801.HK | INNOVENT BIO | Suzhou | China | HKD | HKG | -0.306 | -14.035 | 5568 | https://www.innoventbio.com |
| 300497.SZ | JIANGXI FUSHINE PH | Jingdezhen | China | CNY | SHZ | 0.144 | 35.189 | 1849 | https://www.fushine.cn |
| 300147.SZ | XIANGXUE PHARMACEU | Guangzhou | China | CNY | SHZ | 0.592 | 374.628 | 3378 | https://www.xphcn.com |
| BLUE | bluebird bio, Inc. | Cambridge | United States | USD | NMS | 1.381 | -0.352 | 518 | https://www.bluebirdbio.com |
| 300204.SZ | STAIDSON (BEIJING) | Beijing | China | CNY | SHZ | 0.162 | -27.059 | 873 | https://www.staidson.com |
| AKBA | Akebia Therapeutics, Inc. | Cambridge | United States | USD | NGM | 1.471 | -0.158 | 426 | https://www.akebia.com |
| 1873.HK | VIVA BIOTECH | Shanghai | China | HKD | HKG | 0.952 | 15.936 | 2127 | https://www.vivabiotech.com.cn |
| 300363.SZ | PORTON PHARMA SOLU | Chongqing | China | CNY | SHZ | -0.358 | 30.901 | 4158 | https://www.porton.cn |
| VLON | Vallon Pharmaceuticals Inc. | Philadelphia | United States | USD | NCM | -1.149 | -0.240 | 2 | https://www.vallon-pharma.com |
| SRNE | Sorrento Therapeutics, Inc. | San Diego | United States | USD | NCM | 2.175 | -2.589 | 799 | https://www.sorrentotherapeutics.com |
| NVAX | Novavax, Inc. | Gaithersburg | United States | USD | NMS | 1.579 | -2.578 | 1541 | https://www.novavax.com |
| 300759.SZ | PHARMARON BEIJING | Beijing | China | CNY | SHZ | 0.279 | 49.225 | 14923 | https://www.pharmaron.com |
| 300404.SZ | BOJI MEDICAL & TEC | Guangzhou | China | CNY | SHZ | -0.101 | 63.408 | 989 | https://www.bojicro.com |
| RIGL | Rigel Pharmaceuticals, Inc. | South San Francisco | United States | USD | NMS | 1.664 | -2.332 | 165 | https://www.rigel.com |
| 688180.SS | SHANGHAI JUNSHI BIOSCIENCES CO | Shanghai | China | CNY | SHH | 0.242 | -39.918 | 2805 | https://www.junshipharma.com |
| 600161.SS | BEIJING TIANTAN BIOLOGICAL PROD | Beijing | China | CNY | SHH | 0.016 | 23.288 | 3933 | https://www.tiantanbio.com |
| 9939.HK | KINTOR PHARMA-B | Suzhou | China | HKD | HKG | -0.774 | -5.985 | 316 | https://www.kintor.com.cn |
| VERU | Veru Inc. | Miami | United States | USD | NCM | -0.412 | -41.179 | 252 | https://www.verupharma.com |
Funds
Mutual Fund Holders
Social
Dividends
Ratings
News
Earnings
SEC Filings
Options
Indicators
Glossary
- Momentum
- A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
- Inertia
- In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
- Relative Strength Index (RSI)
- A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
- Fibonacci's Weighted Moving Average
- A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
- Williams %R
- A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
- Relative Volatility Index (RVI)
- A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
- Commodity Channel Index (CCI)
- A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.